- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02266901
Transluminal or Percutaneous Endoscopic Drainage and Debridement of Abcesses After Bariatric Surgery
Study Overview
Detailed Description
This retrospective study in an academic tertiary center will review the files of patients who underwent endoscopic drainage and debridement of abdominal abscesses secondary to bariatric surgery leaks . The decision for endoscopic treatment was made by the medico-surgical team in charge of this type of surgery, who had to weigh the high risk of mortality in case of re-intervention, along with endoscopic access to abscesses via the transluminal or percutaneous route based on abdominal imaging.
Data collection will lead to the evaluation of the technical success rate, the clinical success and potential complications.
Study Type
Enrollment (Actual)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- All the patient treated in an academic tertiary center who underwent endoscopic drainage and debridement of abdominal abscesses secondary to bariatric surgery leaks from october 2007 to April 2011
- septic state
Exclusion Criteria:
- All other necrosectomies performed for pancreatic disorders were excluded from the study
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Cases (endoscopic drainage)
Septic patients presenting post-bariatric collections related to leaks not adequately drained by percutaneous drain, for whom endoscopic drainage of the collections was performed by transluminal or percutaneous route.
|
Endoscopic percutaneous access was obtained through surgical drains or after ultrasound-guided percutaneous drainage with a thin scope , and transluminal procedures with large scopes through the leak hole.
All the procedures were performed under general anesthesia and carbon dioxide insufflation.
Debridement was done by pus aspiration and irrigation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Intervention technical success
Time Frame: during the procedure
|
success to pass the scope and perform abcess debridement of the targeted collection
|
during the procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Clinical success
Time Frame: 7 days
|
success to control sepsis after endoscopic drainage
|
7 days
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Jacques Devière, MD, PhD, Erasme Hospital, ULB
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Bariatric endoscopic drainage
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sepsis
-
University of Kansas Medical CenterUniversity of KansasRecruitingSepsis | Septic Shock | Sepsis Syndrome | Sepsis, Severe | Sepsis Bacterial | Sepsis BacteremiaUnited States
-
Jip GroenInBiomeRecruitingMicrobial Colonization | Neonatal Infection | Neonatal Sepsis, Early-Onset | Microbial Disease | Clinical Sepsis | Culture Negative Neonatal Sepsis | Neonatal Sepsis, Late-Onset | Culture Positive Neonatal SepsisNetherlands
-
The University of QueenslandRoyal Brisbane and Women's HospitalUnknown
-
Karolinska InstitutetÖrebro University, SwedenCompletedSepsis | Sepsis Syndrome | Sepsis, SevereSweden
-
Ohio State UniversityCompletedSepsis, Severe Sepsis and Septic ShockUnited States
-
Indonesia UniversityCompletedSevere Sepsis With Septic Shock | Severe Sepsis Without Septic ShockIndonesia
-
University of LeicesterUniversity Hospitals, Leicester; The Royal College of AnaesthetistsCompletedSepsis | Septic Shock | Severe Sepsis | Sepsis SyndromeUnited Kingdom
-
Beckman Coulter, Inc.Biomedical Advanced Research and Development AuthorityRecruitingSevere Sepsis | Severe Sepsis Without Septic ShockUnited States
-
Weill Medical College of Cornell UniversityNational Heart, Lung, and Blood Institute (NHLBI); New York Presbyterian Hospital and other collaboratorsCompletedSepsis | Septic Shock | Severe Sepsis | Infection | Sepsis SyndromeUnited States
-
Inverness Medical InnovationsCompletedSepsis | Systemic Inflammatory Response Syndrome | Severe Sepsis | Sepsis SyndromeUnited States
Clinical Trials on endoscopic drainage
-
First People's Hospital of HangzhouCompletedCholangitis | ComplicationChina
-
Hospital Universitari de BellvitgeInstitut d'Investigació Biomèdica de Bellvitge; Fundació Institut de Recerca... and other collaboratorsCompletedPancreatic Cancer | Endoscopy | Oncologic Disorders | Therapy Related NeoplasmsSpain
-
Institut Paoli-CalmettesCompletedPancreatic Cancer
-
Central Hospital, Nancy, FranceActive, not recruitingJaundice, Obstructive | Perihilar CholangiocarcinomaFrance
-
Istituto Clinico Humanitas Mater DominiRecruitingDistal Malignant Biliary ObstructionItaly
-
Yiqi DuUnknownPancreatic Pseudocyst
-
Seoul National University HospitalCompletedEfficacyKorea, Republic of
-
Seoul National University HospitalNot yet recruitingAcute Cholecystitis | Biliary Obstruction
-
Assiut UniversityUnknownMalignant Hepatobiliary Neoplasm
-
AdventHealthCompletedPancreatic Neoplasms | Pancreatic Cancer | Pancreatic AdenocarcinomaUnited States